Oncology Today with Dr Neil Love cover image

Metastatic Bladder Cancer — Rapid Case Review Issue 3

Oncology Today with Dr Neil Love

00:00

Biomarker timing and key actionable alterations

Milowsky recommends NGS and HER2 IHC in metastatic disease and notes FGFR3 and HER2 as primary actionable targets.

Play episode from 18:04
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app